These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28124196)

  • 1. Baseline thrombospondin-1 concentrations are not associated with mortality in septic patients: a single-center cohort study on the intensive care unit.
    van der Wekken RJ; Kemperman H; Roest M; de Lange DW
    Intensive Care Med Exp; 2017 Dec; 5(1):7. PubMed ID: 28124196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock.
    Saukkonen K; Lakkisto P; Pettilä V; Varpula M; Karlsson S; Ruokonen E; Pulkki K;
    Clin Chem; 2008 Jun; 54(6):1000-7. PubMed ID: 18420731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma kallistatin in critically ill patients with severe sepsis and septic shock.
    Lin WC; Chen CW; Chao L; Chao J; Lin YS
    PLoS One; 2017; 12(5):e0178387. PubMed ID: 28542440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock.
    Ravetti CG; Moura AD; Vieira ÉL; Pedroso ÊR; Teixeira AL
    J Crit Care; 2015 Apr; 30(2):440.e7-13. PubMed ID: 25541104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of serial measurements of lysophosphatidylcholine on 28-day mortality prediction in patients admitted to the intensive care unit with severe sepsis or septic shock.
    Park DW; Kwak DS; Park YY; Chang Y; Huh JW; Lim CM; Koh Y; Song DK; Hong SB
    J Crit Care; 2014 Oct; 29(5):882.e5-11. PubMed ID: 24961965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients.
    Jabaudon M; Futier E; Roszyk L; Chalus E; Guerin R; Petit A; Mrozek S; Perbet S; Cayot-Constantin S; Chartier C; Sapin V; Bazin JE; Constantin JM
    Crit Care Med; 2011 Mar; 39(3):480-8. PubMed ID: 21220996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site of infection and mortality in patients with severe sepsis or septic shock. A cohort study of patients admitted to a Danish general intensive care unit.
    Klastrup V; Hvass AM; Mackenhauer J; Fuursted K; Schønheyder HC; Kirkegaard H;
    Infect Dis (Lond); 2016 Oct; 48(10):726-31. PubMed ID: 27389656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of a change in septic shock definitions on intensive care epidemiology and outcome: comparison of sepsis-2 and sepsis-3 definitions.
    Driessen RGH; van de Poll MCG; Mol MF; van Mook WNKA; Schnabel RM
    Infect Dis (Lond); 2018 Mar; 50(3):207-213. PubMed ID: 28950786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of age on the innate immune response and outcomes after severe sepsis/septic shock in trauma and surgical intensive care unit patients.
    Brakenridge SC; Efron PA; Stortz JA; Ozrazgat-Baslanti T; Ghita G; Wang Z; Bihorac A; Mohr AM; Brumback BA; Moldawer LL; Moore FA
    J Trauma Acute Care Surg; 2018 Aug; 85(2):247-255. PubMed ID: 29613958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoprotegerin is Higher in Sepsis Than in Noninfectious SIRS and Predicts 30-Day Mortality of SIRS Patients in the Intensive Care.
    Kemperman H; Schrijver IT; Roest M; Kesecioglu J; van Solinge WW; de Lange DW
    J Appl Lab Med; 2019 Jan; 3(4):559-568. PubMed ID: 31639725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in procalcitonin level and outcome in critically ill children with severe sepsis/septic shock-A pilot study.
    Poddar B; Gurjar M; Singh S; Aggarwal A; Baronia A
    J Crit Care; 2016 Dec; 36():230-233. PubMed ID: 27566963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for Sepsis.
    van Vught LA; Klein Klouwenberg PM; Spitoni C; Scicluna BP; Wiewel MA; Horn J; Schultz MJ; Nürnberg P; Bonten MJ; Cremer OL; van der Poll T;
    JAMA; 2016 Apr; 315(14):1469-79. PubMed ID: 26975785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentraxin-3 Predicts Short- and Mid-term Mortality in Patients with Sepsis and Septic Shock During Intensive Care Treatment.
    Hamed S; Behnes M; Pauly D; Lepiorz D; Barre M; Becher T; Lang S; Akin I; Borggrefe M; Bertsch T; Hoffmann U
    Clin Lab; 2018 Jun; 64(6):999-1011. PubMed ID: 29945330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D deficiency at admission is not associated with 90-day mortality in patients with severe sepsis or septic shock: Observational FINNAKI cohort study.
    Ala-Kokko TI; Mutt SJ; Nisula S; Koskenkari J; Liisanantti J; Ohtonen P; Poukkanen M; Laurila JJ; Pettilä V; Herzig KH;
    Ann Med; 2016; 48(1-2):67-75. PubMed ID: 26800186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical management for patients admitted to a critical care unit with severe sepsis or septic shock.
    Cheung WK; Chau LS; Mak II; Wong MY; Wong SL; Tiwari AF
    Intensive Crit Care Nurs; 2015 Dec; 31(6):359-65. PubMed ID: 26292920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combination of SOFA score and biomarkers gives a better prediction of septic AKI and in-hospital mortality in critically ill surgical patients: a pilot study.
    Lee CW; Kou HW; Chou HS; Chou HH; Huang SF; Chang CH; Wu CH; Yu MC; Tsai HI
    World J Emerg Surg; 2018; 13():41. PubMed ID: 30214469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal pro-brain natriuretic peptide and cardiac troponin I for the prognostic utility in elderly patients with severe sepsis or septic shock in intensive care unit: A retrospective study.
    Cheng H; Fan WZ; Wang SC; Liu ZH; Zang HL; Wang LZ; Liu HJ; Shen XH; Liang SQ
    J Crit Care; 2015 Jun; 30(3):654.e9-14. PubMed ID: 25575850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma brain natriuretic peptide and troponin levels in severe sepsis and septic shock: relationships with systolic myocardial dysfunction and intensive care unit mortality.
    Klouche K; Pommet S; Amigues L; Bargnoux AS; Dupuy AM; Machado S; Serveaux-Delous M; Morena M; Jonquet O; Cristol JP
    J Intensive Care Med; 2014; 29(4):229-37. PubMed ID: 23753226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum activin-A as a predictive and prognostic marker in critically ill patients with sepsis.
    Lee JK; Choi SM; Lee J; Park YS; Lee CH; Yim JJ; Yoo CG; Kim YW; Han SK; Lee SM
    Respirology; 2016 Jul; 21(5):891-7. PubMed ID: 26969968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients.
    Donadello K; Scolletta S; Taccone FS; Covajes C; Santonocito C; Cortes DO; Grazulyte D; Gottin L; Vincent JL
    J Crit Care; 2014 Feb; 29(1):144-9. PubMed ID: 24120089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.